Novo Nordisk Invests $1.1 Billion to Expand GLP-1 Drug Manufacturing in Brazil

Novo Nordisk , GLP-1 production , Brazil investment , Wegovy and Ozempic , Diabetes treatment , Obesity treatment , Montes Claros facility , Pharmaceutical manufacturing

Federal Judge Blocks NIH Grant Caps as HHS Appeals Ruling

NIH, HHS, research funding, grant caps, indirect costs, federal judge, permanent injunction, Trump administration, medical research, Administrative Procedure Act, legal appeal, U.S. healthcare policy.

Cellares’ cell therapy factory-in-a-box scores coveted advanced manufacturing technology tag from FDA

Cell Therapy, Advanced Manufacturing Technology, United States Food and Drug Administration, Technology, Identifier, Cell Shuttle, production, Cellares, Biologics License Application, Investigational New Drugs

HHS Overhaul: RFK Jr. Cuts 20,000 Jobs in Major Restructuring

Robert F. Kennedy Jr., Department of Health and Human Services (HHS), job cuts, restructuring, Administration for a Healthy America (AHA), chronic disease epidemic, efficiency, cost-saving